MX2012004082A - Inhibidores de cxcr1/2 como adyuvantes en el trasplante de islotes pancreaticos. - Google Patents

Inhibidores de cxcr1/2 como adyuvantes en el trasplante de islotes pancreaticos.

Info

Publication number
MX2012004082A
MX2012004082A MX2012004082A MX2012004082A MX2012004082A MX 2012004082 A MX2012004082 A MX 2012004082A MX 2012004082 A MX2012004082 A MX 2012004082A MX 2012004082 A MX2012004082 A MX 2012004082A MX 2012004082 A MX2012004082 A MX 2012004082A
Authority
MX
Mexico
Prior art keywords
cxcr1
transplant
inhibitors
pancreatic islets
adjuvants
Prior art date
Application number
MX2012004082A
Other languages
English (en)
Spanish (es)
Inventor
Lorenzo Piemonti
Luisa Daffonchio
Marcello Allegretti
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Publication of MX2012004082A publication Critical patent/MX2012004082A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51Y being a hydrogen or a carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2012004082A 2009-10-06 2010-10-06 Inhibidores de cxcr1/2 como adyuvantes en el trasplante de islotes pancreaticos. MX2012004082A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09172364A EP2308484A1 (en) 2009-10-06 2009-10-06 Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets
PCT/EP2010/064921 WO2011042466A1 (en) 2009-10-06 2010-10-06 Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets

Publications (1)

Publication Number Publication Date
MX2012004082A true MX2012004082A (es) 2012-07-25

Family

ID=41818891

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012004082A MX2012004082A (es) 2009-10-06 2010-10-06 Inhibidores de cxcr1/2 como adyuvantes en el trasplante de islotes pancreaticos.

Country Status (24)

Country Link
US (1) US20120202884A1 (enExample)
EP (2) EP2308484A1 (enExample)
JP (2) JP5834010B2 (enExample)
KR (2) KR101817912B1 (enExample)
CN (2) CN104906572A (enExample)
AU (1) AU2010305385B2 (enExample)
BR (1) BR112012007991B8 (enExample)
CA (1) CA2775902C (enExample)
CY (1) CY1115018T1 (enExample)
DK (1) DK2485723T3 (enExample)
EA (1) EA021298B1 (enExample)
ES (1) ES2451349T3 (enExample)
HK (1) HK1213777A1 (enExample)
HR (1) HRP20140202T1 (enExample)
IL (1) IL219037A (enExample)
ME (1) ME01719B (enExample)
MX (1) MX2012004082A (enExample)
NZ (1) NZ599172A (enExample)
PL (1) PL2485723T3 (enExample)
PT (1) PT2485723E (enExample)
RS (1) RS53249B (enExample)
SI (1) SI2485723T1 (enExample)
SM (1) SMT201400033B (enExample)
WO (1) WO2011042466A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2308485A1 (en) 2009-10-06 2011-04-13 Dompé S.p.a. Sulfonamides for the prevention of diabetes
EP2308484A1 (en) * 2009-10-06 2011-04-13 Dompé S.p.a. Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets
CN103159652B (zh) * 2011-12-19 2016-06-08 天津市国际生物医药联合研究院 亚磺酰胺类化合物的制备及其应用
CN105722972A (zh) 2013-06-18 2016-06-29 纽约大学 参与金黄色葡萄球菌杀白细胞素的细胞毒性的细胞因素:新型治疗靶点
CN109890364B (zh) 2016-10-03 2023-10-17 儿童医疗中心公司 糖尿病肾病的预防和治疗

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303249B1 (it) 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
US20020042370A1 (en) * 2000-04-14 2002-04-11 Millennium Pharmaceuticals, Inc. Method of treating graft rejection using inhibitors of CCR2 function
WO2001078708A1 (en) * 2000-04-14 2001-10-25 Millennium Pharmaceuticals, Inc. Treating graft rejection with cxcr3 inhibitors
ITMI20010206A1 (it) 2001-02-02 2002-08-02 Dompe Spa Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz
PT1776336E (pt) * 2004-03-23 2009-12-18 Dompe Spa Derivados de ácido 2-fenilpropiónico e composições farmacêuticas que os contêm
EP1579859B1 (en) 2004-03-25 2006-12-13 DOMPE' pha.r.ma s.p.a. Use of N-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury
US20050261762A1 (en) * 2004-05-21 2005-11-24 Medtronic Vascular, Inc. Medical devices to prevent or inhibit restenosis
TWI400232B (zh) * 2004-09-13 2013-07-01 Ono Pharmaceutical Co 含氮雜環衍生物及以該含氮雜環衍生物為有效成分之藥劑
JP5232144B2 (ja) * 2006-06-28 2013-07-10 サノフイ Cxcr2阻害剤
JP2010504996A (ja) * 2006-09-26 2010-02-18 ケース ウエスタン リザーブ ユニバーシティ サイトカインシグナリング
WO2009117706A2 (en) 2008-03-20 2009-09-24 Carolus Therapeutics, Inc. Methods of treatment using anti-mif antibodies
EP2308484A1 (en) * 2009-10-06 2011-04-13 Dompé S.p.a. Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets

Also Published As

Publication number Publication date
EP2485723B1 (en) 2013-12-11
SMT201400033B (it) 2014-07-07
BR112012007991A2 (pt) 2017-07-25
EA201270513A1 (ru) 2012-11-30
EA021298B1 (ru) 2015-05-29
DK2485723T3 (en) 2014-03-17
US20120202884A1 (en) 2012-08-09
RS53249B (sr) 2014-08-29
KR101817912B1 (ko) 2018-02-21
KR101759362B1 (ko) 2017-07-18
JP2015145404A (ja) 2015-08-13
CY1115018T1 (el) 2017-01-25
JP2013506704A (ja) 2013-02-28
SI2485723T1 (sl) 2014-06-30
EP2308484A1 (en) 2011-04-13
EP2485723A1 (en) 2012-08-15
ME01719B (me) 2014-09-20
CN102665703A (zh) 2012-09-12
CN102665703B (zh) 2016-04-20
AU2010305385B2 (en) 2016-04-21
JP6097328B2 (ja) 2017-03-15
HRP20140202T1 (en) 2014-05-23
HK1213777A1 (zh) 2016-07-15
BR112012007991B8 (pt) 2021-05-25
AU2010305385A1 (en) 2012-04-26
NZ599172A (en) 2014-03-28
BR112012007991B1 (pt) 2020-12-15
PT2485723E (pt) 2014-03-13
CN104906572A (zh) 2015-09-16
CA2775902A1 (en) 2011-04-14
IL219037A (en) 2015-01-29
IL219037A0 (en) 2012-06-28
JP5834010B2 (ja) 2015-12-16
CA2775902C (en) 2016-11-29
ES2451349T3 (es) 2014-03-26
KR20120083440A (ko) 2012-07-25
HK1175993A1 (zh) 2013-07-19
KR20170068625A (ko) 2017-06-19
PL2485723T3 (pl) 2014-07-31
WO2011042466A1 (en) 2011-04-14

Similar Documents

Publication Publication Date Title
MY149648A (en) Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
MX2010002419A (es) (ciclopropilfenil) feniloxamidas, metodo para su produccion y uso como un medicamento.
MX2010007952A (es) Arilpirrolinas insecticidas.
IN2012DN01233A (enExample)
MX2011011854A (es) Dihidropirimidinonas para uso como inhibidores de la bace2.
BR112012016797A2 (pt) intensificador dinâmico de baixo utilizando compressor com equalizador incorporado
EA201290183A1 (ru) Бензодиазепиновый ингибитор бромодомена
PH12013500329A1 (en) New compounds
PH12013501175A1 (en) 6-amino-2-phenylamino-1h-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin e2 synthase-1 inhibitors
EA201270216A1 (ru) Фармацевтический состав
MX2008010931A (es) Quinolonas utiles como inhibidores de sintasa de oxido nitrico inducibles.
MX2011011733A (es) Inhiibidores de dihidroorotato deshidrogenasa como compuestos virostaticos.
UA104885C2 (uk) Ізотіазолілоксифеніламідини та їх застосування як фунгіцидів
MX2013006802A (es) Inhibidores de neprilisina.
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
MX2011012739A (es) Derivados fluorados de aminotriazol.
EA201171339A1 (ru) Способ снижения внутриглазного давления у людей
PH12013500644A1 (en) Co-crystals and salts of ccr3-inhibitors
IN2012DN01292A (enExample)
WO2011047055A8 (en) Novel mek inhibitors, useful in the treatment of diseases
WO2009105969A8 (zh) 埃坡霉素类似物、其药物组合物、用途及其制备方法
MX2012004082A (es) Inhibidores de cxcr1/2 como adyuvantes en el trasplante de islotes pancreaticos.
UA103329C2 (ru) Соли соединений-ингибиторов вич
MY152040A (en) Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments
MY148732A (en) Triazolium salts as par1 inhibitors, production thereof, and use as medicaments

Legal Events

Date Code Title Description
FG Grant or registration